Paper41007664
Ex Vivo Traceability Platform for Phospholipoproteomic Formulations: Functional Evidence Without Clinical Exposure.
Gutiérrez-Sandoval R and 10 others. Biomedicines, 2025. Cited by 2 papers, by iCite.
Cite this record
ConductScience Library. Ex Vivo Traceability Platform for Phospholipoproteomic Formulations: Functional Evidence Without Clinical Exposure. Papers, record 41007664. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41007664
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Ex Vivo Traceability Platform for Phospholipoproteomic Formulations: Functional Evidence Without Clinical Exposure.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| FB-20222-0871 | Fundación Biotech | PubMed |
Source PubMed
References88
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 36183712 | Traumatic brain injury: progress and challenges in prevention, clinical care, and research. | Lancet Neurol | 2022 | https://conductscience.org/library/papers/36183712 | PubMed |
| 2 | 35742979 | Cellular Environment and Phenotypic Heterogeneity: How Data-Driven Modeling Finds the Smoking Gun. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/35742979 | PubMed |
| 3 | 35760071 | Health Canada Usage of Real World Evidence (RWE) in Regulatory Decision Making compared with FDA/EMA usage based on publicly available information. | J Pharm Pharm Sci | 2022 | https://conductscience.org/library/papers/35760071 | PubMed |
| 4 | 37246765 | Ex vivo to in vivo model of malignant peripheral nerve sheath tumors for precision oncology. | Neuro Oncol | 2023 | https://conductscience.org/library/papers/37246765 | PubMed |
| 5 | 38788712 | A RIPK1-specific PROTAC degrader achieves potent antitumor activity by enhancing immunogenic cell death. | Immunity | 2024 | https://conductscience.org/library/papers/38788712 | PubMed |
| 6 | 36465405 | Metabolism-associated molecular classification of gastric adenocarcinoma. | Front Oncol | 2022 | https://conductscience.org/library/papers/36465405 | PubMed |
| 7 | 39712013 | Modular (universal) CAR-T platforms in vivo: a comprehensive systematic review. | Front Immunol | 2024 | https://conductscience.org/library/papers/39712013 | PubMed |
| 8 | 35342149 | Developing mRNA for Therapy. | Keio J Med | 2022 | https://conductscience.org/library/papers/35342149 | PubMed |
| 9 | 32645020 | Multi-laboratory validation of the xMAP-Food Allergen Detection Assay: A multiplex, antibody-based assay for the simultaneous detection of food allergens. | PLoS One | 2020 | https://conductscience.org/library/papers/32645020 | PubMed |
| 10 | 33000471 | Blockchain technology and traceability in the agrifood industry. | J Food Sci | 2020 | https://conductscience.org/library/papers/33000471 | PubMed |
| 11 | 32314170 | Classifying changes in LN-18 glial cell morphology: a supervised machine learning approach to analyzing cell microscopy data via FIJI and WEKA. | Med Biol Eng Comput | 2020 | https://conductscience.org/library/papers/32314170 | PubMed |
| 12 | 35227601 | Strategies to enhance immunomodulatory properties and reduce heterogeneity in mesenchymal stromal cells during ex vivo expansion. | Cytotherapy | 2022 | https://conductscience.org/library/papers/35227601 | PubMed |
| 13 | 36445343 | Area under the curve: Comparing the value of factor VIII replacement therapies in haemophilia A. | Haemophilia | 2023 | https://conductscience.org/library/papers/36445343 | PubMed |
| 14 | 32559475 | Disease characteristics of MCT8 deficiency: an international, retrospective, multicentre cohort study. | Lancet Diabetes Endocrinol | 2020 | https://conductscience.org/library/papers/32559475 | PubMed |
| 15 | 36571245 | Cross-platform immunophenotyping of human peripheral blood mononuclear cells with four high-dimensional flow cytometry panels. | Cytometry A | 2023 | https://conductscience.org/library/papers/36571245 | PubMed |
| 16 | 36755094 | TET2 guards against unchecked BATF3-induced CAR T cell expansion. | Nature | 2023 | https://conductscience.org/library/papers/36755094 | PubMed |
| 17 | 37138339 | Clinical ethics consultation documentation in the era of open notes. | BMC Med Ethics | 2023 | https://conductscience.org/library/papers/37138339 | PubMed |
| 18 | 38558423 | VDX-111, a novel small molecule, induces necroptosis to inhibit ovarian cancer progression. | Mol Carcinog | 2024 | https://conductscience.org/library/papers/38558423 | PubMed |
| 19 | 32472013 | High-content fluorescence imaging with the metabolic flux assay reveals insights into mitochondrial properties and functions. | Commun Biol | 2020 | https://conductscience.org/library/papers/32472013 | PubMed |
| 20 | 38717950 | CRISPR-Cas Genome Editing in Ex Vivo Human Lungs to Rewire the Translational Path of Genome-Targeting Therapeutics. | Hum Gene Ther | 2024 | https://conductscience.org/library/papers/38717950 | PubMed |
Cited by4
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42942495 | Cell-Free Immune-Conditioned Products in Advanced Solid Tumors: A Source-Aware Translational Framework. | Medicina (Kaunas) | 2026 | https://conductscience.org/library/papers/42942495 | PubMed |
| 42939510 | Source-to-Output Integration of Archived Evidence from an Immunoregulatory-Conditioned Human PBMC Extracellular Preparation. | Curr Issues Mol Biol | 2026 | https://conductscience.org/library/papers/42939510 | PubMed |
| 42514925 | Proteomic Stability and Ex Vivo Compatibility of a Processed Phospholipoproteic Secretome-Derived Formulation. | Pharmaceutics | 2026 | https://conductscience.org/library/papers/42514925 | PubMed |
| 41828528 | Structural Determinants and Repair of Membrane Microdomains in Dendritic Cell-Mediated Antitumor Immunity: An Integrative Mechanistic Synthesis. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/41828528 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41007664
GET https://conductscience.org/api/papers/v1/41007664/references?page=2